Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Compass Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Compass Therapeutics Inc. June 13, 202476.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 3, 2025 | Kymera Therapeutics Inc. | Grant or award | +27,500 | — | — |
| Mar 3, 2025 | Kymera Therapeutics Inc. | Open-market sale | −1,833 | $30.33 | $55,595 |
| Mar 3, 2025 | Kymera Therapeutics Inc. | Open-market sale | −408 | $31.00 | $12,648 |
| Jan 6, 2025 | Kymera Therapeutics Inc. | Open-market sale | −3,129 | $41.75 | $130,636 |
| Mar 1, 2024 | Kymera Therapeutics Inc. | Grant or award | +21,755 | — | — |
| Jan 4, 2024 | Kymera Therapeutics Inc. | Open-market sale | −3,295 | $22.58 | $74,401 |
| Jan 3, 2023 | Kymera Therapeutics Inc. | Grant or award | +37,500 | — | — |
Questions about Ellen Chiniara
What boards is Ellen Chiniara on?
Ellen Chiniara sits on the board of Compass Therapeutics Inc.
How long has Ellen Chiniara served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.